Arrests made in counterfeiting of GSK's weight-loss drug, Alli; FDA guidance covers numerical IDs for drug packaging;

> The Justice Department has made two arrests in the recent counterfeiting of Alli, the weight-loss drug from GSK. Article

> The FDA has issued final guidance, Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages. Guidance

> Despite all the research muscle applied to personalized medicine, little is happening with process development and manufacturing. Article

> State drug regulators in India are on a GMP-violation tear, canceling the licenses of 274 manufacturing units in Maharashtra, 71 units in Mumbai, and 120 in Konkan, among others. Article (subscription required)

> Texas A&M University System is beginning construction on a flexible-by-design therapeutics manufacturing facility for rapid and scalable production of clinical trial supplies. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.